CN / EN

Home >  News Center >  ZY's subsidiary company-BaoFeng Biotech,attended the first CHEXPO Exhibition (MACAO)

ZY's subsidiary company-BaoFeng Biotech,attended the first CHEXPO Exhibition (MACAO)

From December 10th to 12th, the CHEXPO(Macao) was held in Venice Macao people Conference Center. 

 

This exhibition is sponsored by the Ministry of Commerce, guided by the National Administration of Traditional Chinese Medicine, organized by the Trade Development Bureau of the Ministry of Commerce, co-organized by the China Chamber of Commerce for Import and Export of Medicine and Health Products, supported by Macao Trade and Investment Promotion Institute, and supported by chief media of People's Daily Health App.

 

For the first time this year, the CHEXPO (Macao) was held within the MIF exhibition as a single unit, which was highly valued by all parties in Macao. Chief Executive He Yicheng and his delegation visited the exhibition areas of Traditional Chinese Medicine.

图片 1.png

Zhang Boli, Liu Changxiao, Yang Baofeng, Yin Yulong, academicians of Chinese Academy of Engineering, and Chen Kaixian, academician of Chinese Academy of Sciences with leading industry experts attended the conference online and offline, gathering with well-known pharmaceutical entrepreneurs, experts of new drug research and development, and more than 100 leading enterprises and research institutions of domestic traditional medicine and big health industry. Titled "Joining hands with the TCM (traditional Chinese medicine) big health industry, build a healthy China 2030", the party will explore the deep integration mechanism of " production-learning-research", promote the R&D and industrial transformation capacity of TCM, and jointly promote the innovative development of TCM industry.

图片 2.png

A subsidiary company of ZHONGYUAN, BaoFeng Biotech Co., Ltd., which is a cutting-edge biotechnology company focusing on the technology of brain science, Brain health screening, and Brain health product R&D. The company has set up R&D centers, production bases, and raw material bases in Beijing, Jilin, Zhuhai, Inner Mongolia, etc. BaoFeng’s project of Biological nervonic acid pharmaceutical industry in Dunhua City, Jilin Province has been completed, which will become a production and research base for the extraction of nervonic acid, special medical food, and drug R&D. BaoFeng Biotech is honored to participate in the CHEXPO (Macao) on behalf of pharmaceutical enterprises in Jilin Province.

 

Since its establishment in 2012, BaoFeng Biotech has always taken "Striving for human’s life and health" as its mission, and at the same time shoulders the burden of reviving traditional Chinese medicine culture. Using Acer truncatum as raw materials, a unique maple tree species in China, BaoFeng Biotech has brought a series of brain health products rich in nervonic acid. We hope that this exhibition can spread the traditional Chinese medicine culture and healthy concepts to the public, and benefit China by Acer truncatum.

Nervonic Acid Neuro Enhancer, Acer Truncatum Seed Oil, Nervonic Acid Candy and Miraculous Maple Edible Vegetable Blended Oil, etc. produced by BaoFeng Biotech appeared one by one, lending many highlights and popularity to Jilin big health industry exhibition area.

图片 3.png图片 4.png

On the day of the exhibition, the area of Jilin's big health industry ushered a key guest: He Yicheng, the Chief Executive, visited the Jilin Exhibition group and stopped at the Exhibition area of BaoFeng Biotech company. He highly recognized and appreciated the health technology platform of early-screening and intervention in the field of the nervous system.

图片 5.png图片 6.png


He Yicheng, Chief Executive, visited Jilin Exhibition Area

In the International Cooperation and Development Forum of the conference, Macao NPC Deputy He Jinglin said that Guangdong-Macao In-Depth Cooperation Zone in Hengqin has already set up "Traditional Chinese Medicine Science and Technology Industrial Park of Co-operation between Guangdong and Macao". In the future, the development of traditional Chinese medicine should be taken as the axis to promote the establishment of cross-border developmental aggregation and linkage relationship of the traditional Chinese medicine industries between Macao and other regions.

 

With a view at the conference theme " Innovative research and development, industrial transformation and international expansion of Chinese medicine”, Ms. Chang Tingting, the founder and CEO of BaoFeng Biotech, expounded meticulously and comprehensively the process of Acer truncatum project, including planting, making medicine, declaration of new nervonic acid botanical innovative medicine. A discussion is taken on the declaration and cooperation of products’ landing in Macao. 

图片 7.png图片 8.png

Ms. Chang Tingting, founder and CEO of Baofeng Biotech Company, delivered a speech

Ms. Chang Tingting delivered a speech on stage, saying that BaoFeng Biotech also established BaoFeng Biotech (Hengqin, Zhuhai) in the Traditional Chinese Medicine Science and Technology Industrial Park of Co-operation between Guangdong and Macao, which is mainly responsible for research projects such as extraction of nervonic acid, pharmacology research, and application of Traditional Chinese medicine, as well as deepening cooperation with The Traditional Chinese medicine industries between Guangdong and Macao.

 

In September this year, the enaction of “Overall Plan for the Construction of Guangdong-Macao In-Depth Cooperation Zone in Hengqin” and the unveiling of the administrative institutions of Guangdong-Macao In-Depth Cooperation Zone in Hengqin has brought greater development opportunities to the traditional Chinese medicine industry. BaoFeng Biotech will closely follow the constructive pace of Guangdong-Macao In-Depth Cooperation Zone in Hengqin, actively build a Macao brand industry of traditional Chinese medicine, meanwhile aiming at making greater contributions to the Guangdong-Hong Kong-Macao Greater Bay Area.

 

BaoFeng Biotech also gained a lot in this exhibition and communicated deeply with many leading companies of medical industries on the innovation and development of traditional Chinese medicine. We also hope that through this exhibition, the public can realize the determination of BaoFeng Biotech to conquer brain diseases, guide more people to establish a scientific concept of health preservation by using traditional Chinese medicine, and contribute to the spread and inheritance of traditional Chinese medicine culture! In the future, BaoFeng Biotech will keep original intentions and continue to achieve new progress on the development road of neuroscience.

 





Last:To the Shareholders of Zhongyuan Bio-Technology Holdings, Limited. Return Next:BF co-builds “Key Laboratory of Genetic Metabolism Research”